6 Lumbar Spinal Stenosis Myths the Research Contradicts

Anne Osborn, PT, MPT Anne Osborn, PT, MPT
8 minute read

Physical therapist reviewing a lumbar MRI with a patient in an outpatient clinic, discussing lumbar spinal stenosis myths and treatment options

Listen to resource
Audio generated by DropInBlog's Blog Voice AI™ may have slight pronunciation nuances. Learn more

Table of Contents

Clinical Summary:

The Gap: Most of what clinicians were taught about lumbar spinal stenosis is older than the patient on the table. The last three years of evidence rewrites the triage, the exercise selection, and the surgical decision logic.

The Evidence: Six durable myths now sit directly against high-quality 2022–2025 data: Shahidi (imaging severity), Nordsten-DS 2024 (fusion question), Wesselink (paraspinal muscle quality), Armon AAN 2025 (epidural injections), and multiple convergence trials.

The Takeaway: If your stenosis algorithm hasn't changed since 2020, it's lagging the literature. The six corrections below are the highest-yield updates.

Most experienced clinicians can name the conventional teaching on lumbar spinal stenosis from memory: severe MRI gets surgical referral, rest the back, fuse the spondylolisthesis, save the epidural for last. None of that is straightforwardly wrong. All of it has been complicated by evidence from the last three years.

These are the six lumbar spinal stenosis myths the 2024 research contradicts most directly. Each one is something a clinician would say in a hallway conversation without anyone batting an eye, and each one now sits against a randomized trial, a recent cohort, or a 2025 guideline.

Myth 1: Severe Stenosis on MRI Means the Patient Needs Surgery

What clinicians say: "Her central canal is obliterated at L4-L5. She's not going to respond to rehab, we should send her out."

What the research shows: Shahidi and colleagues directly examined whether radiographic stenosis severity predicts responsiveness to exercise-based rehabilitation. It does not. Mild, moderate, and severe grades all demonstrated similar patterns of improvement with appropriate intervention.

Clinical implication: Imaging confirms the diagnosis and rules out red-flag pathology. It does not triage who gets a conservative trial. The patient with severe imaging and preserved walking distance is exactly the patient for whom rehabilitation is most likely to succeed.

What to do instead: Use the N-CLASS criteria, walking tolerance, and progression of symptoms to triage. Reserve imaging-driven referral for red flags, not severity grade.

Imaging severity does not predict who responds to lumbar spinal stenosis rehabilitation. That's not a soft finding. That's a 2024 cohort result that should change a referral pattern.

Myth 2: Patients with Neurogenic Claudication Need to Rest

What clinicians say: "Walking hurts her. She needs to back off until it settles."

What the research shows: Deconditioning compounds stenosis disability in a documented downward spiral: reduced walking leads to cardiovascular decline, weight gain, and reduced neural and muscular reserve. None of which reverses spontaneously. Aerobic exercise in a flexed posture (cycling, aquatic, inclined treadmill) is well tolerated even when level walking is not.

The Posture Effect:

30 min

Of cycling tolerated by patients who cannot walk one city block, because lumbar flexion preserves canal dimensions.

Clinical implication: "Rest" is not a treatment plan. Rest is the activity restriction that makes future surgery more likely.

What to do instead: Within the first two weeks, prescribe 15 to 30 minutes of stationary cycling, three to five days per week, at conversational intensity. Layer flexion-based exercise and trunk stabilization on top.

Myth 3: Spondylolisthesis with Stenosis Requires Fusion

What clinicians say: "There's a slip. They'll need a fusion with the decompression to stabilize it."

What the research shows: The Nordsten-DS five-year results, published in BMJ in 2024, randomized degenerative spondylolisthesis patients to decompression alone versus decompression plus fusion. No significant difference in Oswestry Disability Index, leg pain, back pain, or quality of life at five years. The Gadjradj systematic review and the Cheng meta-analysis arrive at the same conclusion across multiple studies.

Clinical implication: Adding fusion adds operative time, blood loss, and complication risk without outcome benefit for typical grade 1 degenerative spondylolisthesis. Fusion remains appropriate for high-grade slip or gross instability. The standard of care is shifting.

What to do instead: When coordinating post-surgical care, expect decompression alone to be the increasingly common procedure even when a slip is present. Plan rehabilitation accordingly. The Nordsten-DS five-year results are worth reading in full if you have a referring surgeon still defaulting to fusion.


Product Spotlight:


Myth 4: Surgery Is the Definitive Solution

What clinicians say: "Once she has the decompression, this will be behind her."

What the research shows: Reported reoperation rates after initial decompression range from 4 to 23 percent at ten-year follow-up, depending on cohort. Complication rates run 10 to 24 percent. Approximately one-third of surgical patients report treatment nonsuccess at long-term follow-up. Long-term outcomes between surgical and conservative arms converge at six to eight years.

Surgery is a faster path. The destination is the same. Patients who hear that earlier engage in conservative care differently.

Clinical implication: Surgery is a legitimate option with a real short-term advantage. It is not, by the data, a more durable solution.

What to do instead: Frame the conversation honestly. Surgery is faster relief; rehabilitation is slower but ends in the same place at six to eight years, with lower complication and reoperation risk. Let the patient choose with that information.

Myth 5: Frail or Elderly Patients Can't Tolerate Rehabilitation

What clinicians say: "He's 82 with diabetes and a fall history. He's not going to do PT."

What the research shows: Frailty and high comorbidity burden predict worse baseline function and slower recovery trajectories. They do not predict failure of rehabilitation. The Takase comparative study found that patients 75 and older achieved meaningful functional improvements with appropriate intervention. The Wesselink five-year cohort identified paraspinal multifidus fat (not age) as the strongest single-variable predictor of post-decompression recovery.

Clinical implication: The patient who is denied a rehabilitation trial because of age and comorbidities is the same patient who is most likely to face poor surgical outcomes if rehabilitation isn't tried first. The default needs to flip.

What to do instead: Modify the modality, not the trial. Aquatic therapy reduces axial spinal load by roughly 50 percent and unloads peripheral joints simultaneously. Recumbent cycling and seated programming bypass standing tolerance. Expectations on rate and magnitude of gain calibrate; the direction does not.

Did You Know?

Hyperpolypharmacy (10 or more concurrent medications) has been associated with significantly worse surgical outcomes in lumbar spinal stenosis cohorts (Kawabata et al.). The same patients, if shifted to rehabilitation, may benefit from medication review as part of the prehabilitation conversation, particularly for sedating and dependency-producing agents that complicate exercise participation.

Myth 6: Epidural Steroid Injection Is a Last Resort Before Surgery

What clinicians say: "We'll send her for an injection if she fails PT, before we talk about surgery."

What the research shows: The 2025 American Academy of Neurology synthesis by Armon and colleagues, drawing on 90 RCTs, found that epidural steroid injection possibly reduces short-term and long-term disability in lumbar spinal stenosis (NNT = 4 short-term, NNT = 8 long-term) but evidence is insufficient for pain reduction. Kim and colleagues found that patients with moderate stenosis responded better to injection than patients with severe stenosis.

Clinical implication: Saving injection for the last conservative step before surgery may miss the window where it produces the most benefit. Injection earlier (paired with a structured rehabilitation push during the four-to-six-week window of reduced symptoms) may be the higher-yield sequencing.

What to do instead: Coordinate with the interventional provider so injection timing supports a rehabilitation intensification, not a passive waiting period. The window after injection is when the harder exercise progressions become tolerable.

Why These Myths Persist

None of these lumbar spinal stenosis myths are clinical errors in the bad-clinician sense. They are the previous standard. Most clinicians learned them in school, saw them confirmed in early practice, and never had a forcing function to update. The Nordsten-DS five-year publication landed in 2024. The Shahidi imaging-doesn't-predict cohort is recent. The Wesselink paraspinal muscle paper is recent. The Armon AAN guideline is from 2025.

The clinicians who stay current on this kind of evidence are the ones who keep their referral relationships, their outcomes, and their professional identity intact across decades. The ones who don't, eventually find themselves saying things in clinic that the patient sitting across from them has already read on a research summary. The full operating model for the current evidence sits in the Ridley Learning course, and the deeper imaging analysis is in the imaging severity evidence blog.

The Bottom Line

The six biggest lumbar spinal stenosis myths all rest on evidence that no longer holds. Imaging severity doesn't predict rehab response. Rest worsens function. Fusion adds risk without benefit for typical spondylolisthesis. Surgery isn't a more durable solution. Frailty doesn't preclude rehabilitation. And epidural injection works better earlier than later. The clinicians who update on these six points hand their patients a better algorithm than the one most of us were taught.


REFERENCES

FAQs

Which of these lumbar spinal stenosis myths is the most clinically consequential to address first?

The imaging severity myth, because it drives triage. Once a clinician stops using MRI severity as a referral trigger, the conservative trial gets offered to the right patients. Most of the other myths flow from this one, including the assumption that severe imaging predicts surgical necessity.

If decompression alone matches decompression plus fusion at five years, when is fusion still appropriate?

High-grade spondylolisthesis (grade 2 and above), gross radiographic or clinical instability, or revision surgery in selected cases. For typical degenerative grade 1 spondylolisthesis with stenosis, decompression alone is now the better-supported approach. Surgeon practice patterns are lagging the evidence in many systems.

How do I talk to a patient who wants surgery now because their neighbor had it and recovered fast?

Honor their preference but present the data: surgery is faster relief, with a 10 to 24 percent complication rate and 4 to 23 percent reoperation risk at ten years. Conservative care is slower but reaches the same outcome at six to eight years with lower risk. Shared decision-making means showing both sides.

What is the minimum supervised rehabilitation trial that counts as adequate before considering surgery?

Six to twelve weeks, twice weekly supervised, multimodal: manual therapy, flexion-based exercise, trunk stabilization, aerobic conditioning in flexed posture, structured patient education. Brief or unsupervised home programs are not equivalent and do not match the comparator arms in the trials.

Does early epidural steroid injection change the rehabilitation conversation?

Potentially yes. The 2025 AAN synthesis suggests modest disability benefit, with best response in moderate (not severe) stenosis. Coordinating injection timing with a rehabilitation intensification window (the four to six weeks of reduced symptoms post-injection) may improve outcomes more than reserving injection as a pre-surgical last step.

Professional Disclaimer

This content is for informational purposes for licensed clinicians and does not constitute medical advice or a substitute for your own clinical research and judgment. Content may include AI-synthesized information; all clinical data, protocols, and dosages must be verified against official primary sources prior to patient care. Any reference to CE rules or regulations is provided as a guide and must be independently verified against current governing body requirements prior to completing credits. This article may contain links to external websites or third-party AI platforms. Ridley Learning has no control over the nature, content, and availability of those sites and does not necessarily endorse the views expressed within them. Ridley Learning is not liable for any injury, loss, clinical outcomes, or licensure issues resulting from the use of or reliance on this information. Your use of this site constitutes acceptance of these terms.

Anne Perry Osborn, PT, MPT - Headshot

Meet the Author:
Anne Osborn, PT, MPT

Anne Perry Osborn is a distinguished physical therapist and entrepreneur with over two decades of experience bridging clinical practice and healthcare education. She holds a Master of Physical Therapy from Texas Tech University Health Sciences Center and currently serves as the Owner and Director of Quality and Accreditation at Ridley Learning. With a background that includes clinical roles in outpatient rehabilitation and home health, Anne brings practical, hands-on insight to her leadership in continuing education, ensuring that learning opportunities remain relevant and impactful for today's practitioners.

 Read More & View Courses 

Unlimited CE Membership

Get Unlimited Access CE

To get CE Credit for learning in this subject, check out the Unlimited Access membership - and get courses on this subject and more! With an Unlimited Access CE Membership, you get instant access to courses to meet your CE needs — whenever you need them.

 Learn More About Unlimited CE 

« Back to Blog